{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:22:26Z","timestamp":1793125346609,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.diagmicrobio.2025.116804","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T19:27:19Z","timestamp":1742066839000},"page":"116804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The evolving epidemiology of antimicrobial resistance of ESKAPE pathogens isolated in the intensive care unit of a Greek university hospital"],"prefix":"10.1016","volume":"112","author":[{"given":"Sofia","family":"Maraki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria Eirini","family":"Mavromanolaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kasimati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Iliaki-Giannakoudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Stafylaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.diagmicrobio.2025.116804_bib0001","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116804_bib0002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0003","unstructured":"CDC's 2019 antibiotic resistance threats report. https:\/\/www.multivu.com\/players\/English\/8627551-cdc-antibiotic-resistance-threat-report-2019 (accessed January 7, 2025)."},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0004","article-title":"Tackling drug-resistant infections globally: final report and recommendations","author":"O'Neill","year":"2016","journal-title":"London: Rev Antimicrob Resist"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116804_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.102544","article-title":"The influence of efflux pump, outer membrane permeability and \u03b2-lactamase production on the resistance profile of multi, extensively and pandrug resistant Klebsiella pneumoniae","volume":"17","author":"Hussein","year":"2024","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116804_bib0006","doi-asserted-by":"crossref","first-page":"e41670","DOI":"10.1016\/j.heliyon.2025.e41670","article-title":"Molecular characterization and genome sequencing of selected highly resistant clinical isolates of Pseudomonas aeruginosa and its association with the clustered regularly interspaced palindromic repeat\/Cas system","volume":"11","author":"Owaid","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0007","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/IDR.S147459","article-title":"Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece","volume":"10","author":"Kritsotakis","year":"2017","journal-title":"Infect Drug Resist"},{"issue":"13","key":"10.1016\/j.diagmicrobio.2025.116804_bib0008","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/healthcare11131946","article-title":"Antimicrobial resistance: a growing serious threat for global public health","volume":"11","author":"Salam","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens","volume":"2016","author":"Santajit","year":"2016","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116804_bib0010","first-page":"S910","article-title":"Molecular detection and sequencing of SHV gene encoding for extended-spectrum \u03b2-lactamases produced by multidrug resistance some of the gram-negative bacteria","volume":"12","author":"Khalaf","year":"2018","journal-title":"Int J Green Pharmacy"},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0011","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for antimicrobial susceptibility testing; 32th ed. (M100-Ed32)."},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0012","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation for MICs and zone diameters: version 12.0, valid from 2022-01-01. EUCAST, Basel, Switzerland."},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.116804_bib0013","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1128\/JCM.03361-13","article-title":"Modified CLSI extended-spectrum beta-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various beta-lactamases","volume":"52","author":"Poulou","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2025.116804_bib0014","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.00404-11","article-title":"Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae","volume":"49","author":"Polsfuss","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116804_bib0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189621","article-title":"Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis","volume":"12","author":"Founou","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2025.116804_bib0017","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jinf.2014.09.004","article-title":"Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance","volume":"70","author":"Fitzpatrick","year":"2015","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2025.116804_bib0018","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10096-023-04616-7","article-title":"In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study","volume":"42","author":"Galani","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0019","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/antibiotics8020062","article-title":"A 2-year single-centre audit on antibiotic resistance of Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae strains from an intensive care unit and other wards in a general public hospital in Greece","volume":"8","author":"Feretzakis","year":"2019","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116804_bib0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41426-018-0038-9","article-title":"Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries","volume":"7","author":"Xie","year":"2018","journal-title":"Emerg Microb Infect"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116804_bib0021","first-page":"S959","article-title":"AS. Identification of an OprD and bla(IMP) gene-mediated carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa among patients with wound infections in Iraq","volume":"12","author":"Al-Ouqaili","year":"2018","journal-title":"Asian J Pharm"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116804_bib0022","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116804_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jhin.2024.04.013","article-title":"Risk factors for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infection of patients admitted in intensive care unit: a systematic review and meta-analysis","volume":"149","author":"Diao","year":"2024","journal-title":"J Hosp Infect"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116804_bib0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jhin.2020.09.009","article-title":"Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients","volume":"106","author":"Karakonstantis","year":"2020","journal-title":"J Hosp Infect"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.116804_bib0026","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/CCM.0000000000000510","article-title":"Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa","volume":"42","author":"Kollef","year":"2014","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116804_bib0027","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s12879-018-3413-1","article-title":"Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: a multicenter prospective cohort study","volume":"18","author":"Gomila","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0028","first-page":"26","article-title":"European Centre for Disease Prevention and Control: Antimicrobial Resistance Surveillance in EU\/EEA (EARS-Net): annual epidemiological report for2022","year":"2022","journal-title":"Stockholm, ECDC,"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116804_bib0029","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/antibiotics12040670","article-title":"Pseudomonas bacteremia in a tertiary hospital and factors associated with mortality","volume":"12","author":"Ioannou","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116804_bib0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/erp.10.49","article-title":"Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes","volume":"10","author":"Hirsch","year":"2010","journal-title":"Expert Rev Pharmacoecon Outcome Res"},{"issue":"5-6","key":"10.1016\/j.diagmicrobio.2025.116804_bib0031","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000437252","article-title":"Susceptibility of 2,252 Pseudomonas aeruginosa clinical isolates over 4 years to 9 antimicrobials in a tertiary Greek hospital","volume":"60","author":"Maraki","year":"2014","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116804_bib0032","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","article-title":"Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact","volume":"50","author":"Aloush","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116804_bib0033","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QCO.0000000000000182","article-title":"The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria","volume":"28","author":"Perez","year":"2015","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.116804_bib0034","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s15010-021-01735-1","article-title":"Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates","volume":"50","author":"Maraki","year":"2022","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116804_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/14787210.2021.1935237","article-title":"Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies","volume":"20","author":"Karaiskos","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.diagmicrobio.2025.116804_bib0036","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/fmb-2016-0216","article-title":"In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece","volume":"12","author":"Maraki","year":"2017","journal-title":"Future Microbiol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.116804_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107115","article-title":"Enterobacterales carrying chromosomal AmpC \u03b2-lactamases in Europe (EuESCPM): epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020-2022","volume":"63","author":"Boattini","year":"2024","journal-title":"Int J Antimicrob Agent"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116804_bib0038","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/23744235.2015.1110858","article-title":"Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012-2013","volume":"48","author":"Souli","year":"2016","journal-title":"Infect Dis (Lond)"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2025.116804_bib0039","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10096-005-0060-4","article-title":"Control of methicillin-resistant Staphylococcus aureus in the UK","volume":"24","author":"Gould","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116804_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and Prevention, 2009-2010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 5","key":"10.1016\/j.diagmicrobio.2025.116804_bib0041","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1086\/533592","article-title":"Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains","volume":"46","author":"Sakoulas","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.116804_bib0042","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200003093421007","article-title":"Vancomycin-resistant enterococcal infections","volume":"342","author":"Murray","year":"2000","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2025.116804_bib0043","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/antibiotics12071088","article-title":"Impact of SARS-CoV-2 preventive measures against healthcare-associated infections from antibiotic-resistant ESKAPEE pathogens: A two-center, natural quasi-experimental study in Greece","volume":"12","author":"Bolikas","year":"2023","journal-title":"Antibiotics (Basel)"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325001270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325001270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T09:51:57Z","timestamp":1752573117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325001270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0732889325001270"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116804","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolving epidemiology of antimicrobial resistance of ESKAPE pathogens isolated in the intensive care unit of a Greek university hospital","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116804"}}